The Prostate Health Index in predicting initial prostate biopsy outcomes in Asian men with prostate-specific antigen levels of 4–10 ng/mL

Author： Ng C.   Chiu Peter   Lam N.   Lam H.   Lee Kim   Hou Simon  

Publisher： Springer Publishing Company

ISSN： 0301-1623

Source： International Urology and Nephrology, Vol.46, Iss.4, 2014-04, pp. : 711-717

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Clinical value of human glandular kallikrein 2 and free and total prostate-specific antigen in serum from a population of men with prostate-specific antigen levels 3.0 ng/mL or greater

By Becker C.   Piironen T.   Pettersson K.   Hugosson J.   Lilja H.  

Urology, Vol. 55, Iss. 5, 2000-05 ,pp. : 694-699

Elsevier

Access to resources Recommend Favorite

Diagnostic significance of digital rectal examination and transrectal ultrasonography in men with prostate-specific antigen levels of 4 ng/mL or less

By Yamamoto T.   Ito K.   Ohi M.   Kubota Y.   Suzuki K.   Fukabori Y.   Kurokawa K.   Yamanaka H.  

Urology, Vol. 58, Iss. 6, 2001-12 ,pp. : 994-998

Elsevier

Access to resources Recommend Favorite

Use of percentage of free prostate-specific antigen to identify men at high risk of prostate cancer when psa levels are 2.51 to 4 ng/mL and digital rectal examination is not suspicious for prostate cancer: an alternative model

By Catalona W.J.   Partin A.W.   Finlay J.A.   Chan D.W.   Rittenhouse H.G.   Wolfert R.L.   Woodrum D.L.  

Urology, Vol. 54, Iss. 2, 1999-08 ,pp. : 220-224

Elsevier

Access to resources Recommend Favorite

Development of a nomogram that predicts the probability of a positive prostate biopsy in men with an abnormal digital rectal examination and a prostate-specific antigen between 0 and 4 ng/mL

By Eastham J.A.   May R.   Robertson J.L.   Sartor O.   Kattan M.W.  

Urology, Vol. 54, Iss. 4, 1999-10 ,pp. : 709-713

Elsevier

Access to resources Recommend Favorite

Prostate-specific antigen cutoff of 2.6 ng/mL for prostate cancer screening is associated with favorable pathologic tumor features

By Krumholtz J.S.   Carvalhal G.F.   Ramos C.G.   Smith D.S.   Thorson P.   Yan Y.   Humphrey P.A.   Roehl K.A.   Catalona W.J.  

Urology, Vol. 60, Iss. 3, 2002-09 ,pp. : 469-473

Elsevier

Access to resources Recommend Favorite